BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 34599760)

  • 1. Characterization of SARS-CoV-2 and common cold coronavirus-specific T-cell responses in MIS-C and Kawasaki disease children.
    Hsieh LE; Grifoni A; Sidney J; Shimizu C; Shike H; Ramchandar N; Moreno E; Tremoulet AH; Burns JC; Franco A
    Eur J Immunol; 2022 Jan; 52(1):123-137. PubMed ID: 34599760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.
    Chen MR; Kuo HC; Lee YJ; Chi H; Li SC; Lee HC; Yang KD
    Front Immunol; 2021; 12():632890. PubMed ID: 33732254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T Cells in Multisystem Inflammatory Syndrome in Children (MIS-C) Have a Predominant CD4+ T Helper Response to SARS-CoV-2 Peptides and Numerous Virus-Specific CD4- CD8- Double-Negative T Cells.
    Hsieh LE; Song J; Grifoni A; Shimizu C; Tremoulet AH; Dummer KB; Burns JC; Sette A; Franco A
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited induction of SARS-CoV-2-specific T cell responses in children with multisystem inflammatory syndrome compared with COVID-19.
    Singh V; Obregon-Perko V; Lapp SA; Horner AM; Brooks A; Macoy L; Hussaini L; Lu A; Gibson T; Silvestri G; Grifoni A; Weiskopf D; Sette A; Anderson EJ; Rostad CA; Chahroudi A
    JCI Insight; 2022 Feb; 7(4):. PubMed ID: 35044955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyclonal expansion of TCR Vbeta 21.3
    Moreews M; Le Gouge K; Khaldi-Plassart S; Pescarmona R; Mathieu AL; Malcus C; Djebali S; Bellomo A; Dauwalder O; Perret M; Villard M; Chopin E; Rouvet I; Vandenesh F; Dupieux C; Pouyau R; Teyssedre S; Guerder M; Louazon T; Moulin-Zinsch A; Duperril M; Patural H; Giovannini-Chami L; Portefaix A; Kassai B; Venet F; Monneret G; Lombard C; Flodrops H; De Guillebon JM; Bajolle F; Launay V; Bastard P; Zhang SY; Dubois V; Thaunat O; Richard JC; Mezidi M; Allatif O; Saker K; Dreux M; Abel L; Casanova JL; Marvel J; Trouillet-Assant S; Klatzmann D; Walzer T; Mariotti-Ferrandiz E; Javouhey E; Belot A
    Sci Immunol; 2021 May; 6(59):. PubMed ID: 34035116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2-Specific T Cell Responses Are Stronger in Children With Multisystem Inflammatory Syndrome Compared to Children With Uncomplicated SARS-CoV-2 Infection.
    Conway SR; Lazarski CA; Field NE; Jensen-Wachspress M; Lang H; Kankate V; Durkee-Shock J; Kinoshita H; Suslovic W; Webber K; Smith K; Cohen JI; Burbelo PD; Zhang A; Teach SJ; Ibeh T; Delaney M; DeBiasi RL; Keller MD; Bollard CM
    Front Immunol; 2021; 12():793197. PubMed ID: 35116027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similarities and differences between the immunopathogenesis of COVID-19-related pediatric multisystem inflammatory syndrome and Kawasaki disease.
    Esteve-Sole A; Anton J; Pino-Ramirez RM; Sanchez-Manubens J; Fumadó V; Fortuny C; Rios-Barnes M; Sanchez-de-Toledo J; Girona-Alarcón M; Mosquera JM; Ricart S; Launes C; de Sevilla MF; Jou C; Muñoz-Almagro C; González-Roca E; Vergara A; Carrillo J; Juan M; Cuadras D; Noguera-Julian A; Jordan I; Alsina L
    J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33497356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease.
    Bukulmez H
    Curr Rheumatol Rep; 2021 Jul; 23(8):58. PubMed ID: 34216296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers.
    da Silva Antunes R; Pallikkuth S; Williams E; Dawen Yu E; Mateus J; Quiambao L; Wang E; Rawlings SA; Stadlbauer D; Jiang K; Amanat F; Arnold D; Andrews D; Fuego I; Dan JM; Grifoni A; Weiskopf D; Krammer F; Crotty S; Hoffer ME; Pahwa SG; Sette A
    J Infect Dis; 2021 Jul; 224(1):70-80. PubMed ID: 33822097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome.
    Huang JJ; Gaines SB; Amezcua ML; Lubell TR; Dayan PS; Dale M; Boneparth AD; Hicar MD; Winchester R; Gorelik M
    J Allergy Clin Immunol; 2022 Mar; 149(3):912-922. PubMed ID: 34688775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay.
    Cassaniti I; Percivalle E; Bergami F; Piralla A; Comolli G; Bruno R; Vecchia M; Sambo M; Colaneri M; Zuccaro V; Benazzo M; Robotti C; Calastri A; Maiorano E; Ferrari A; Cambiè G; Baldanti F
    Clin Microbiol Infect; 2021 Jul; 27(7):1029-1034. PubMed ID: 33813122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children.
    Beckmann ND; Comella PH; Cheng E; Lepow L; Beckmann AG; Tyler SR; Mouskas K; Simons NW; Hoffman GE; Francoeur NJ; Del Valle DM; Kang G; Do A; Moya E; Wilkins L; Le Berichel J; Chang C; Marvin R; Calorossi S; Lansky A; Walker L; Yi N; Yu A; Chung J; Hartnett M; Eaton M; Hatem S; Jamal H; Akyatan A; Tabachnikova A; Liharska LE; Cotter L; Fennessy B; Vaid A; Barturen G; Shah H; Wang YC; Sridhar SH; Soto J; Bose S; Madrid K; Ellis E; Merzier E; Vlachos K; Fishman N; Tin M; Smith M; Xie H; Patel M; Nie K; Argueta K; Harris J; Karekar N; Batchelor C; Lacunza J; Yishak M; Tuballes K; Scott I; Kumar A; Jaladanki S; Agashe C; Thompson R; Clark E; Losic B; Peters L; ; Roussos P; Zhu J; Wang W; Kasarskis A; Glicksberg BS; Nadkarni G; Bogunovic D; Elaiho C; Gangadharan S; Ofori-Amanfo G; Alesso-Carra K; Onel K; Wilson KM; Argmann C; Bunyavanich S; Alarcón-Riquelme ME; Marron TU; Rahman A; Kim-Schulze S; Gnjatic S; Gelb BD; Merad M; Sebra R; Schadt EE; Charney AW
    Nat Commun; 2021 Aug; 12(1):4854. PubMed ID: 34381049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children.
    Ramaswamy A; Brodsky NN; Sumida TS; Comi M; Asashima H; Hoehn KB; Li N; Liu Y; Shah A; Ravindra NG; Bishai J; Khan A; Lau W; Sellers B; Bansal N; Guerrerio P; Unterman A; Habet V; Rice AJ; Catanzaro J; Chandnani H; Lopez M; Kaminski N; Dela Cruz CS; Tsang JS; Wang Z; Yan X; Kleinstein SH; van Dijk D; Pierce RW; Hafler DA; Lucas CL
    Immunity; 2021 May; 54(5):1083-1095.e7. PubMed ID: 33891889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection.
    Berardicurti O; Conforti A; Ruscitti P; Cipriani P; Giacomelli R
    Expert Rev Clin Immunol; 2020 Dec; 16(12):1205-1215. PubMed ID: 33152254
    [No Abstract]   [Full Text] [Related]  

  • 16. The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19.
    Consiglio CR; Cotugno N; Sardh F; Pou C; Amodio D; Rodriguez L; Tan Z; Zicari S; Ruggiero A; Pascucci GR; Santilli V; Campbell T; Bryceson Y; Eriksson D; Wang J; Marchesi A; Lakshmikanth T; Campana A; Villani A; Rossi P; ; Landegren N; Palma P; Brodin P
    Cell; 2020 Nov; 183(4):968-981.e7. PubMed ID: 32966765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses.
    Dykema AG; Zhang B; Woldemeskel BA; Garliss CC; Cheung LS; Choudhury D; Zhang J; Aparicio L; Bom S; Rashid R; Caushi JX; Hsiue EH; Cascino K; Thompson EA; Kwaa AK; Singh D; Thapa S; Ordonez AA; Pekosz A; D'Alessio FR; Powell JD; Yegnasubramanian S; Zhou S; Pardoll DM; Ji H; Cox AL; Blankson JN; Smith KN
    J Clin Invest; 2021 May; 131(10):. PubMed ID: 33830946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children.
    Lee PY; Day-Lewis M; Henderson LA; Friedman KG; Lo J; Roberts JE; Lo MS; Platt CD; Chou J; Hoyt KJ; Baker AL; Banzon TM; Chang MH; Cohen E; de Ferranti SD; Dionne A; Habiballah S; Halyabar O; Hausmann JS; Hazen MM; Janssen E; Meidan E; Nelson RW; Nguyen AA; Sundel RP; Dedeoglu F; Nigrovic PA; Newburger JW; Son MBF
    J Clin Invest; 2020 Nov; 130(11):5942-5950. PubMed ID: 32701511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Review with an Emphasis on Mucocutaneous and Kawasaki Disease-Like Findings.
    Marzano AV; Cassano N; Moltrasio C; Verdoni L; Genovese G; Vena GA
    Dermatology; 2022; 238(1):35-43. PubMed ID: 34062530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection.
    Carter MJ; Fish M; Jennings A; Doores KJ; Wellman P; Seow J; Acors S; Graham C; Timms E; Kenny J; Neil S; Malim MH; Tibby SM; Shankar-Hari M
    Nat Med; 2020 Nov; 26(11):1701-1707. PubMed ID: 32812012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.